FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

716017002: Idarucizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3304446011 Idarucizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3304447019 Idarucizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Idarucizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Idarucizumab Is a Antidote true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing idarucizumab Has active ingredient True Idarucizumab Inferred relationship Existential restriction modifier 1
Product containing idarucizumab in parenteral dose form (medicinal product form) Has active ingredient True Idarucizumab Inferred relationship Existential restriction modifier 1
Idarucizumab Has active ingredient True Idarucizumab Inferred relationship Existential restriction modifier 1
Product containing only idarucizumab in parenteral dose form (medicinal product form) Has active ingredient True Idarucizumab Inferred relationship Existential restriction modifier 1
Product containing precisely idarucizumab 50 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Idarucizumab Inferred relationship Existential restriction modifier 1
Product containing precisely idarucizumab 50 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance True Idarucizumab Inferred relationship Existential restriction modifier 1
Idarucizumab 2.5g/50ml solution for infusion vials 2 vial Has specific active ingredient True Idarucizumab Inferred relationship Existential restriction modifier
Idarucizumab 2.5g/50ml solution for infusion vials Has specific active ingredient True Idarucizumab Inferred relationship Existential restriction modifier
Praxbind 2.5g/50ml solution for infusion vials (Boehringer Ingelheim Ltd) Has specific active ingredient True Idarucizumab Inferred relationship Existential restriction modifier
Praxbind 2.5g/50ml solution for infusion vials (Boehringer Ingelheim Ltd) 2 vial Has specific active ingredient True Idarucizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start